Federico Daray
Professor in Pharmacology, University of Buenos Aires
Location: Argentina
Recently Online
Consulting Services
Areas Of Interest
Professional Narrative
While making my career from 1998 to 2006, I start doing Basic Research in the Pharmacology Department of the School of Medicine at the University of Buenos Aires. As a result of these years of work, I obtained my Ph.D. in Pharmacology. My Thesis was related to inflammation and oxidative stress, and it was classified as outstanding and received the award for the best Thesis from the School of Medicine in 2008. Then I started my psychiatry residency at the “Braulio A. Moyano” Neuropsychiatric Hospital; since then, mood disorders and suicidal behavior have been the main interest in my career as a psychiatrist. During my residency training, I managed to rotate in the “Mood Disorders Program” at Tufts Medical Center in Boston under Dr. Nassir Ghaemi’s supervision. When returning to Argentina, I worked as a Clinical Research Fellow at the Institute for Clinical Effectiveness while performing the Master’s Program in Clinical Effectiveness. This is one of the most prestigious Clinical Research Master's in Latin America, and it is carried out in collaboration and with the assistance of professors from Harvard University. From there, my career had a significant boost locally. Thanks to this success, in 2012, I entered the Researcher Career at the National Council of Scientific Research of Argentina (CONICET) and achieved a stable position as a full-time researcher. I have progressed in the different statuses of my career year after year, currently holding the position of Independent Researcher. Based on my work in CONICET, I won a research fellowship from the Argentinean Government to work as Adjunct Associate Research Scientist in the Division of Molecular Imaging and Neuropathology at New York State Psychiatric Institute, Columbia University, under the supervision of Dr. JJ Mann and Elizabeth Sublette. This allowed me to see how a clinical research study is planned and executed, meet and interact with researchers from all over the world, observe the most relevant lines of research, become familiar with the grant application processes, and present my results to top-level scientists. After this experience, I have focused my research on inflammation and immune system activation in patients with mood disorders and suicidal behavior. Thanks to this experience, I have obtained two international grants as a young researcher, one from the American Foundation For Suicide Prevention (AFSP) and the other from the Brain Behavior Research Foundation (BBRF). The latter is still ongoing and has a high relationship with the project I am presenting here. Nowadays, I am a Professor of Pharmacology and Director of the Psychopharmacology Laboratory at the Institute of Pharmacology in the School of Medicine of the University of Buenos Aires. We share a laboratory with Dr. Errasti Andrea, the Director of the Immunology Laboratory, collaborating on three grants related to the immune response in patients with mood disorders.
Employment
Education
Referees
Publications
1: Harel D, Levis B, Sun Y, Fischer F, Ioannidis JPA, Cuijpers P, Patten SB, Ziegelstein RC, Markham S, Benedetti A, Thombs BD; DEPRESsion Screening Data DEPRESSD PHQ Collaboration. External validation of a shortened screening tool using individual participant data meta-analysis: A case study of the Patient Health Questionnaire-Dep-4. Methods. 2022 Aug;204:300-311. doi: 10.1016/j.ymeth.2021.11.005. Epub 2021 Nov 12. PMID: 34780986.
2: Puppo S, Cormick G, Gibbons L, Rodríguez R, Correa M, Smith J, Marroquín V, Rozic P, Belizán JM, Schvartzman JA, Daray FM. The peripartum period involvement in the development of post-partum depression. A prospective cohort study. J Psychosom Res. 2022 Apr;155:110748. doi: 10.1016/j.jpsychores.2022.110748. Epub 2022 Feb 3. PMID: 35134693.
3: Rodante DE, Kaplan MI, Olivera Fedi R, Gagliesi P, Pascali A, José Quintero PS, Compte EJ, Perez AI, Weinstein M, Chiapella LC, Daray FM. CALMA, a Mobile Health Application, as an Accessory to Therapy for Reduction of Suicidal and Non-Suicidal Self-Injured Behaviors: A Pilot Cluster Randomized Controlled Trial. Arch Suicide Res. 2022 Apr-Jun;26(2):801-818. doi: 10.1080/13811118.2020.1834476. Epub 2020 Oct 18. PMID: 33073745.
4: Grendas LN, Chiapella L, Rodante DE, Daray FM. Comparison of traditional model-based statistical methods with machine learning for the prediction of suicide behaviour. J Psychiatr Res. 2021 Nov 23;145:85-91. doi: 10.1016/j.jpsychires.2021.11.029. Epub ahead of print. PMID: 34883411.
5: Negeri ZF, Levis B, Sun Y, He C, Krishnan A, Wu Y, Bhandari PM, Neupane D, Brehaut E, Benedetti A, Thombs BD; Depression Screening Data (DEPRESSD) PHQ Group. Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: updated systematic review and individual participant data meta-analysis. BMJ. 2021 Oct 5;375:n2183. doi: 10.1136/bmj.n2183. PMID: 34610915; PMCID: PMC8491108.
6: Wu Y, Levis B, Sun Y, He C, Krishnan A, Neupane D, Bhandari PM, Negeri Z, Benedetti A, Thombs BD; DEPRESsion Screening Data (DEPRESSD) HADS Group. Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. 2021 May 10;373:n972. doi: 10.1136/bmj.n972. Erratum in: BMJ. 2021 May 19;373:n1231. PMID: 33972268; PMCID: PMC8107836.
7: Cormick G, Puppo S, Vazquez PF, Gibbons L, Rodriguez R, Bosio MV, Cano-Leon L, Villareal L, Correa M, Rozic P, Belizán JM, Schvartzman JA, Daray FM. Factors associated with depression during pregnancy in women from a low socioeconomic level: A hierarchical model approach. Psychiatry Res. 2021 Apr;298:113798. doi: 10.1016/j.psychres.2021.113798. Epub 2021 Feb 9. PMID: 33601072.
8: Daray FM, Grendas LN, Rodante DE, Errasti AE, Cases GG, Moix CF, Uicich RE, GimÉnez MI, Puppo S, Fasolino GH, Portela A, Galfalvy HC, Sublette ME. Polyunsaturated fatty acids as predictors of future suicide attempt. Prostaglandins Leukot Essent Fatty Acids. 2021 Feb;165:102247. doi: 10.1016/j.plefa.2021.102247. Epub 2021 Jan 12. PMID: 33482466.
9: Fornaro M, Daray FM, Hunter F, Anastasia A, Stubbs B, De Berardis D, Shin JI, Husain MI, Dragioti E, Fusar-Poli P, Solmi M, Berk M, Vieta E, Carvalho AF. The prevalence, odds and predictors of lifespan comorbid eating disorder among people with a primary diagnosis of bipolar disorders, and vice-versa: Systematic review and meta-analysis. J Affect Disord. 2021 Feb 1;280(Pt A):409-431. doi: 10.1016/j.jad.2020.11.015. Epub 2020 Nov 13. PMID: 33227671.
10: Wu Y, Levis B, Ioannidis JPA, Benedetti A, Thombs BD; DEPRESsion Screening Data (DEPRESSD) Collaboration. Probability of Major Depression Classification Based on the SCID, CIDI, and MINI Diagnostic Interviews: A Synthesis of Three Individual Participant Data Meta-Analyses. Psychother Psychosom. 2021;90(1):28-40. doi: 10.1159/000509283. Epub 2020 Aug 19. PMID: 32814337; PMCID: PMC8993569.
11: Prokopez CR, Vallejos M, Farinola R, Alberio G, Caporusso GB, Cozzarin LG, Chiapella LC, Fuentes P, Daray FM. The history of multiple adverse childhood experiences in patients with schizophrenia is associated with more severe symptomatology and suicidal behavior with gender-specific characteristics. Psychiatry Res. 2020 Nov;293:113411. doi: 10.1016/j.psychres.2020.113411. Epub 2020 Aug 18. PMID: 32890864.
12: Levis B, Sun Y, He C, Wu Y, Krishnan A, Bhandari PM, Neupane D, Imran M, Brehaut E, Negeri Z, Fischer FH, Benedetti A, Thombs BD; Depression Screening Data (DEPRESSD) PHQ Collaboration; Che L, Levis A, Riehm K, Saadat N, Azar M, Rice D, Boruff J, Kloda L, Cuijpers P, Gilbody S, Ioannidis J, McMillan D, Patten S, Shrier I, Ziegelstein R, Moore A, Akena D, Amtmann D, Arroll B, Ayalon L, Baradaran H, Beraldi A, Bernstein C, Bhana A, Bombardier C, Buji RI, Butterworth P, Carter G, Chagas M, Chan J, Chan LF, Chibanda D, Cholera R, Clover K, Conway A, Conwell Y, Daray F, de Man-van Ginkel J, Delgadillo J, Diez- Quevedo C, Fann J, Field S, Fisher J, Fung D, Garman E, Gelaye B, Gholizadeh L, Gibson L, Goodyear-Smith F, Green E, Greeno C, Hall B, Hampel P, Hantsoo L, Haroz E, Harter M, Hegerl U, Hides L, Hobfoll S, Honikman S, Hudson M, Hyphantis T, Inagaki M, Ismail K, Jeon HJ, Jetté N, Khamseh M, Kiely K, Kohler S, Kohrt B, Kwan Y, Lamers F, Asunción Lara M, Levin-Aspenson H, Lino V, Liu SI, Lotrakul M, Loureiro S, Löwe B, Luitel N, Lund C, Marrie RA, Marsh L, Marx B, McGuire A, Mohd Sidik S, Munhoz T, Muramatsu K, Nakku J, Navarrete L, Osório F, Patel V, Pence B, Persoons P, Petersen I, Picardi A, Pugh S, Quinn T, Rancans E, Rathod S, Reuter K, Roch S, Rooney A, Rowe H, Santos I, Schram M, Shaaban J, Shinn E, Sidebottom A, Simning A, Spangenberg L, Stafford L, Sung S, Suzuki K, Swartz R, Tan PLL, Taylor-Rowan M, Tran T, Turner A, van der Feltz-Cornelis C, van Heyningen T, van Weert H, Wagner L, Li Wang J, White J, Winkley K, Wynter K, Yamada M, Zhi Zeng Q, Zhang Y. Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis. JAMA. 2020 Jun 9;323(22):2290-2300. doi: 10.1001/jama.2020.6504. PMID: 32515813; PMCID: PMC7284301.
13: Wu Y, Levis B, Sun Y, Krishnan A, He C, Riehm KE, Rice DB, Azar M, Yan XW, Neupane D, Bhandari PM, Imran M, Chiovitti MJ, Saadat N, Boruff JT, Cuijpers P, Gilbody S, McMillan D, Ioannidis JPA, Kloda LA, Patten SB, Shrier I, Ziegelstein RC, Henry M, Ismail Z, Loiselle CG, Mitchell ND, Tonelli M, Al-Adawi S, Beraldi A, Braeken APBM, Büel-Drabe N, Bunevicius A, Carter G, Chen CK, Cheung G, Clover K, Conroy RM, Cukor D, da Rocha E Silva CE, Dabscheck E, Daray FM, Douven E, Downing MG, Feinstein A, Ferentinos PP, Fischer FH, Flint AJ, Fujimori M, Gallagher P, Gandy M, Goebel S, Grassi L, Härter M, Jenewein J, Jetté N, Julião M, Kim JM, Kim SW, Kjærgaard M, Köhler S, Loosman WL, Löwe B, Martin-Santos R, Massardo L, Matsuoka Y, Mehnert A, Michopoulos I, Misery L, Navines R, O'Donnell ML, Öztürk A, Peceliuniene J, Pintor L, Ponsford JL, Quinn TJ, Reme SE, Reuter K, Rooney AG, Sánchez-González R, Schwarzbold ML, Senturk Cankorur V, Shaaban J, Sharpe L, Sharpe M, Simard S, Singer S, Stafford L, Stone J, Sultan S, Teixeira AL, Tiringer I, Turner A, Walker J, Walterfang M, Wang LJ, White J, Wong DK, Benedetti A, Thombs BD. Probability of major depression diagnostic classification based on the SCID, CIDI and MINI diagnostic interviews controlling for Hospital Anxiety and Depression Scale - Depression subscale scores: An individual participant data meta-analysis of 73 primary studies. J Psychosom Res. 2020 Feb;129:109892. doi: 10.1016/j.jpsychores.2019.109892. Epub 2019 Dec 13. PMID: 31911325.
14: Grendas LN, Rojas SM, Rodante DE, Puppo S, Vidjen P, Portela A, Daray FM. Differential Impact of Child Sexual Abuse and Family History of Suicidal Behavior in High-Risk Suicidal Patients. Arch Suicide Res. 2020;24(sup2):S251-S263. doi: 10.1080/13811118.2019.1592040. Epub 2019 May 7. PMID: 30955484.
15: Santero M, Daray FM, Prado C, Hernández-Vásquez A, Irazola V. Association between religiosity and depression varies with age and sex among adults in South America: Evidence from the CESCAS I study. PLoS One. 2019 Dec 16;14(12):e0226622. doi: 10.1371/journal.pone.0226622. PMID: 31841570; PMCID: PMC6913958.
16: Nowak W, Grendas LN, Sanmarco LM, Estecho IG, Arena ÁR, Eberhardt N, Rodante DE, Aoki MP, Daray FM, Carrera Silva EA, Errasti AE. Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR. EBioMedicine. 2019 Dec;50:290-305. doi: 10.1016/j.ebiom.2019.10.063. Epub 2019 Nov 18. PMID: 31753725; PMCID: PMC6921226.
17: Daray FM, Hunter F, Anastasia A, Fornaro M. Psychometric properties of the Patient Health Questionnaire nine-item version (PHQ-9) for use among hospitalized non-psychiatric medical patients. Gen Hosp Psychiatry. 2019 Nov- Dec;61:69-75. doi: 10.1016/j.genhosppsych.2019.10.004. Epub 2019 Oct 23. PMID: 31715389.
18: Grendas LN, Rojas SM, Puppo S, Vidjen P, Portela A, Chiapella L, Rodante DE, Daray FM. Interaction between prospective risk factors in the prediction of suicide risk. J Affect Disord. 2019 Nov 1;258:144-150. doi: 10.1016/j.jad.2019.07.071. Epub 2019 Jul 30. PMID: 31401542.
19: Rojas SM, Skinner KD, Feldner MT, Rodante DE, Puppo S, Vidjen P, Portela A, Grendas LN, Daray FM. Lethality of Previous Suicidal Behavior among Patients Hospitalized for Suicide Risk Predicts Lethality of Future Suicide Attempts. Suicide Life Threat Behav. 2019 Oct;49(5):1431-1438. doi: 10.1111/sltb.12538. Epub 2018 Nov 29. PMID: 30488985.
20: Urtasun M, Daray FM, Teti GL, Coppolillo F, Herlax G, Saba G, Rubinstein A, Araya R, Irazola V. Validation and calibration of the patient health questionnaire (PHQ-9) in Argentina. BMC Psychiatry. 2019 Sep 18;19(1):291. doi: 10.1186/s12888-019-2262-9. PMID: 31533674; PMCID: PMC6751851.
21: Rodante DE, Grendas LN, Puppo S, Vidjen P, Portela A, Rojas SM, Chiapella LC, Daray FM. Predictors of short- and long-term recurrence of suicidal behavior in borderline personality disorder. Acta Psychiatr Scand. 2019 Aug;140(2):158-168. doi: 10.1111/acps.13058. Epub 2019 Jun 20. PMID: 31155713.
22: Daray FM, Goldmann E, Gutierrez L, Ponzo J, Lanas F, Mores N, Calandrelli M, Poggio R, Watkins BX, Irazola V. Suicidal ideation is associated with cardiovascular disease in a large, urban cohort of adults in the Southern Cone of Latin America. Gen Hosp Psychiatry. 2019 Mar-Apr;57:34-40. doi: 10.1016/j.genhosppsych.2018.12.006. Epub 2018 Dec 18. PMID: 30710890.
23: Daray FM, Arena ÁR, Armesto AR, Rodante DE, Puppo S, Vidjen P, Portela A, Grendas LN, Errasti AE. Serotonin transporter gene polymorphism as a predictor of short-term risk of suicide reattempts. Eur Psychiatry. 2018 Oct;54:19-26. doi: 10.1016/j.eurpsy.2018.07.001. Epub 2018 Jul 20. PMID: 30036761.
24: Daray FM, Mann JJ, Sublette ME. How lipids may affect risk for suicidal behavior. J Psychiatr Res. 2018 Sep;104:16-23. doi: 10.1016/j.jpsychires.2018.06.007. Epub 2018 Jun 12. PMID: 29920417; PMCID: PMC6102068.
25: Pham D, Cormick G, Amyx MM, Gibbons L, Doty M, Brown A, Norwood A, Daray FM, Althabe F, Belizán JM. Factors associated with postpartum depression in women from low socioeconomic level in Argentina: A hierarchical model approach. J Affect Disord. 2018 Feb;227:731-738. doi: 10.1016/j.jad.2017.11.091. Epub 2017 Nov 21. PMID: 29179143; PMCID: PMC5805649.
26: Daray FM, Olivera Fedi RH, Rodante DE. Desarrollo de CALMA: una aplicación para dispositivos móviles inteligentes para la prevención del suicidio en adolescentes y jóvenes [Development of CALMA: A mobile APP for the prevention of suicide in adolescents and youth]. Vertex. 2018 Jan;29(137):55-64. Spanish. PMID: 30605196.
27: Grendas L, Rodante D, Rojas S, Puppo S, Vidjen P, Lado G, Portela A, Daray FM. Determinants of mental and physical health-related quality of life among patients hospitalized for suicidal behavior. Psychiatry Res. 2017 Nov;257:56-60. doi: 10.1016/j.psychres.2017.07.029. Epub 2017 Jul 14. PMID: 28734236.
28: Daray FM, Rubinstein AL, Gutierrez L, Lanas F, Mores N, Calandrelli M, Poggio R, Ponzo J, Irazola VE. Determinants and geographical variation in the distribution of depression in the Southern cone of Latin America: A population- based survey in four cities in Argentina, Chile and Uruguay. J Affect Disord. 2017 Oct 1;220:15-23. doi: 10.1016/j.jad.2017.05.031. Epub 2017 May 21. PMID: 28575715.
29: Daray FM, Rodante D, Carosella LG, Silva ME, Martínez M, Fernández Busch MV, Faccone DF, Rothlin RP, Maffía PC. -759C>T Polymorphism of the HTR2C Gene is Associated with Second Generation Antipsychotic-Induced Weight Gain in Female Patients with Schizophrenia. Pharmacopsychiatry. 2017 Jan;50(1):14-18. doi: 10.1055/s-0042-110321. Epub 2016 Jul 14. PMID: 27414739.
30: Rodante D, Rojas SM, Feldner MT, Dutton C, Rebok F, Teti GL, Grendas L, Fógola A, Daray FM. Differences between female suicidal patients with family history of suicide attempt and family history of completed suicide. Compr Psychiatry. 2016 Oct;70:25-31. doi: 10.1016/j.comppsych.2016.06.006. Epub 2016 Jun 13. PMID: 27624420.
31: Daray FM, Rojas SM, Bridges AJ, Badour CL, Grendas L, Rodante D, Puppo S, Rebok F. The independent effects of child sexual abuse and impulsivity on lifetime suicide attempts among female patients. Child Abuse Negl. 2016 Aug;58:91-8. doi: 10.1016/j.chiabu.2016.06.011. Epub 2016 Jun 25. PMID: 27352091.
32: Prokopez CR, Armesto AR, Gil Aguer MF, Balda MV, Papale RM, Bignone IM, Daray FM. Clozapine Rechallenge After Neutropenia or Leucopenia. J Clin Psychopharmacol. 2016 Aug;36(4):377-80. doi: 10.1097/JCP.0000000000000512. PMID: 27232877.
33: Yanzón de la Torre A, Oliva N, Echevarrieta PL, Pérez BG, Caporusso GB, Titaro AJ, Todaro Kicyla A, Cuatz M, Locatelli M, Nelson LM, Mac Mullen M, Baldessarini RJ, Daray FM. Major depression in hospitalized Argentine general medical patients: Prevalence and risk factors. J Affect Disord. 2016 Jun;197:36-42. doi: 10.1016/j.jad.2016.02.066. Epub 2016 Mar 2. PMID: 26967917.
34: Daray FM, Grendas L, Rebok F. Cambios en la conceptualización de la conducta suicida a lo largo de la historia: desde la antigüedad hasta el DSM-5 [Changes in the conceptualization of suicidal behavior throughout history: from antiquity to the DSM-5.]. Rev Fac Cien Med Univ Nac Cordoba. 2016;73(3):205-211. Spanish. PMID: 27805559.
35: Daray FM. La oportunidad de transformar el modelo de atención en salud mental de la Argentina en un modelo basado en fundamentos científicos a partir de la Ley Nacional de Salud Mental [The opportunity to transform the model of mental health care of Argentina to a model based on scientific evidence based on the National Mental Health Law]. Vertex. 2015 Sep;XXVI(123):382-389. Spanish. PMID: 27066606.
36: Daray FM. La oportunidad de transformar el modelo de atención en salud mental de la Argentina en un modelo basado en fundamentos científicos a partir de la Ley Nacional de Salud Mental [THE OPPORTUNITY TO TRANSFORM THE MODEL OF MENTAL HEALTH CARE OF ARGENTINA TO A MODEL BASED ON SCIENTIFIC EVIDENCE BASED ON THE NATIONAL MENTAL HEALTH LAW]. Vertex. 2015 Sep-Oct;26(123):382-9. Spanish. PMID: 26966757.
37: Balda MV, Daray FM. Farmacovigilancia intensiva de clozapina en Argentina [Intensive pharmacovigilance of clozapine in Argentina]. Vertex. 2015 Jul- Aug;26(122):292-301. Spanish. PMID: 26672506.
38: Balda MV, Garay OU, Papale RM, Bignone I, Bologna VG, Brandolini A, Prokopez CR, Balasini JI, Baldessarini RJ, Daray FM. Clozapine-associated neutropenia and agranulocytosis in Argentina (2007-2012). Int Clin Psychopharmacol. 2015 Mar;30(2):109-14. doi: 10.1097/YIC.0000000000000060. PMID: 25486383.
39: Rebok F, Teti GL, Fantini AP, Cárdenas-Delgado C, Rojas SM, Derito MN, Daray FM. Types of borderline personality disorder (BPD) in patients admitted for suicide-related behavior. Psychiatr Q. 2015 Mar;86(1):49-60. doi: 10.1007/s11126-014-9317-3. PMID: 25179870.
40: Daray FM, Teti GL, Rojas SM, Fantini AP, Cárdenas-Delgado C, Armesto A, Derito MN, Rebok F. Time Left for Intervention in the Suicidal Process in Borderline Personality Disorder. Arch Suicide Res. 2015;19(4):489-99. doi: 10.1080/13811118.2014.1002875. PMID: 25699990.
41: Teti GL, Rebok F, Rojas SM, Grendas L, Daray FM. Systematic review of risk factors for suicide and suicide attempt among psychiatric patients in Latin America and Caribbean. Rev Panam Salud Publica. 2014 Aug;36(2):124-33. PMID: 25345534.
42: Teti GL, Rebok F, Grendas LN, Rodante D, Fógola A, Daray FM. Pacientes hospitalizadas por ideación e intento de suicidio en un Hospital de Salud Mental: características clínico-demográficas y seguimiento a seis meses [Patients hospitalized for suicidal ideation and suicide attempt in a Mental Health Hospital: Clinicodemographical features and 6-month follow-up]. Vertex. 2014 May-Jun;25(115):203-12. Spanish. PMID: 25546542.
43: Sakariassen KS, Femia EA, Daray FM, Podda GM, Razzari C, Pugliano M, Errasti AE, Armesto AR, Nowak W, Alberts P, Meyer JP, Sorensen AS, Cattaneo M, Rothlin RP. EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin. Thromb Res. 2012 Nov;130(5):746-52. doi: 10.1016/j.thromres.2012.08.309. Epub 2012 Sep 5. PMID: 22959706.
44: Daray FM, Maffia PC, Rothlin RP, Errasti AE. Farmacogenética en psiquiatría: ¿qué tan lejos estamos de su aplicación clínica? [Pharmacogenetics in psychiatry: how far are we from clinical application?]. Vertex. 2012 Jul- Aug;23(104):299-309. Spanish. PMID: 23170302.
45: Daray FM, Thommi SB, Ghaemi SN. The pharmacogenetics of antidepressant- induced mania: a systematic review and meta-analysis. Bipolar Disord. 2010 Nov;12(7):702-6. doi: 10.1111/j.1399-5618.2010.00864.x. PMID: 21040287.
46: Errasti AE, del-Rey G, Cesio CE, Souza G, Nowak W, Pelorosso FG, Daray FM, Rothlin RP. Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein. Eur J Pharmacol. 2009 May 21;610(1-3):68-74. doi: 10.1016/j.ejphar.2009.03.022. Epub 2009 Mar 14. PMID: 19289115.
47: Rebok F, Pérez Roldán ML, Daray FM. Acerca del delirio hipocondríaco en las Parafrenias: una revisión historiográfica y clínica [Hypochondriacal delusions in paraphrenias: a historiographical and clinical review]. Vertex. 2009 May- Jun;20(85):213-20. Spanish. PMID: 19652777.
48: Rebok F, Pérez Roldán ML, Daray FM. Reacciones adversas cutáneas debidas a psicofármacos [Cutaneous side effects due to psychiatric drugs]. Vertex. 2008 Nov-Dec;19(82):348-56. Spanish. PMID: 19424517.
49: Errasti AE, Luciani LI, Cesio CE, Tramontano J, Boveris D, Daray FM, Nowak W, Pelorosso FG, Rothlin RP. Potentiation of adrenaline vasoconstrictor response by sub-threshold concentrations of U-46619 in human umbilical vein: involvement of smooth muscle prostanoid TP(alpha) receptor isoform. Eur J Pharmacol. 2007 May 21;562(3):227-35. doi: 10.1016/j.ejphar.2007.01.085. Epub 2007 Feb 15. PMID: 17362923.
50: Nowak W, Goldschmidt ED, Falcioni AG, Pugliese MI, Errasti AE, Pelorosso FG, Daray FM, Gago JE, Rothlin RP. Functional evidence of des-Arg10-kallidin enzymatic inactivating pathway in isolated human umbilical vein. Naunyn Schmiedebergs Arch Pharmacol. 2007 May;375(3):221-9. doi: 10.1007/s00210-007-0145-y. Epub 2007 Mar 20. PMID: 17372720.
51: Daray FM, Colombo JR, Kibrik JR, Errasti AE, Pelorosso FG, Nowak W, Cracowski JL, Rothlin RP. Involvement of endothelial thromboxane A2 in the vasoconstrictor response induced by 15-E2t-isoprostane in isolated human umbilical vein. Naunyn Schmiedebergs Arch Pharmacol. 2006 Aug;373(5):367-75. doi: 10.1007/s00210-006-0074-1. PMID: 16738877.
52: Daray FM, Minvielle AI, Puppo S, Rothlin RP. Vasoconstrictor effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F(2alpha) on human umbilical vein. Eur J Pharmacol. 2004 Sep 19;499(1-2):189-95. doi: 10.1016/j.ejphar.2004.07.100. PMID: 15363966.
53: Errasti AE, Werneck de Avellar MC, Daray FM, Tramontano J, Luciani LI, Lina Bard MJ, Maróstica E, Rothlin RP. Human umbilical vein vasoconstriction induced by epinephrine acting on alpha1B-adrenoceptor subtype. Am J Obstet Gynecol. 2003 Nov;189(5):1472-80. doi: 10.1067/s0002-9378(03)00646-x. PMID: 14634588.
54: Daray FM, Minvielle AI, Puppo S, Rothlin RP. Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein. Br J Pharmacol. 2003 Aug;139(8):1409-16. doi: 10.1038/sj.bjp.0705375. PMID: 12922927; PMCID: PMC1573974.
55: Errasti AE, Rey-Ares V, Daray FM, Rogines-Velo MP, Sardi SP, Paz C, Podestá EJ, Rothlin RP. Human umbilical vein: involvement of cyclooxygenase-2 pathway in bradykinin B1 receptor-sensitized responses. Naunyn Schmiedebergs Arch Pharmacol. 2001 Aug;364(2):149-56. doi: 10.1007/s002100100434. PMID: 11534854.
56: Sardi SP, Daray FM, Errasti AE, Pelorosso FG, Pujol-Lereis VA, Rey-Ares V, Rogines-Velo MP, Rothlin RP. Further pharmacological characterization of bradykinin B1 receptor up-regulation in human umbilical vein. J Pharmacol Exp Ther. 1999 Sep;290(3):1019-25. PMID: 10454473.
Grants,Awards and Certifications
Grants :
No Grants Mentioned !!
Awards & Prizes :
